Event Date
The FDA’s proposed rule ending the voluntary GRAS (“generally recognized as safe”) notification program was published August 11, 2026. For food biotech startups and the ingredient supply chain, this changes both the cost of bringing a new ingredient to market and how buyers evaluate supplier risk. Join UC Davis and SciPinion for a one-hour webinar on what’s changing, what it means for your filing strategy, and how it reshapes supplier due diligence across the CPG supply chain.
Who Should Attend
This free webinar is open to food biotech founders and R&D leads, academics, researchers, accelerators and investors supporting food ingredient portfolio companies.
Agenda
- The GRAS Program, then and now: FDA’s proposed rule changes
- What it means for startups: Filing requirements and key decision points
- The supply chain ripple effect: How post-market surveillance reshapes supplier risk and buyer due diligence
- Live poll: A quick gut-check on where your own documentation stands
- How SciBridge helps: Tools built for this moment
- Live Q&A
Featured Speaker
Vanessa Feher Castagna, PhD Dr. Vanessa Feher Castagna serves as the Director of Food Safety and Claims at SciPinion, where she leads the SciBridge program for food ingredient safety review.
Moderator
Mike Lemcke Mike Lemcke is the Director of the Aggie Venture Accelerator (AVA), and Associate Director of New Venture Resources at Venture Catalyst, within the Innovation and Economic Development Office at UC Davis.